Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Laos has been experiencing certain trends and developments in recent years.
Customer preferences: Laos has a population of around 7 million people with a large proportion living in rural areas. The country has a high infant mortality rate, and as a result, the government has been working towards improving the healthcare system. However, there is still a lack of awareness about the importance of vaccines, and many people do not have access to basic healthcare facilities. This has resulted in a low demand for vaccines, including Other Vaccines.
Trends in the market: The Other Vaccines market in Laos has been growing at a slow pace due to the low demand for vaccines. However, there has been an increase in the number of people who are becoming aware of the importance of vaccines, which has led to a slight increase in demand. In addition, the government has been working towards improving the healthcare system, which has led to better access to vaccines.
Local special circumstances: Laos is a landlocked country in Southeast Asia with a developing economy. The country is heavily dependent on agriculture, and the majority of the population relies on subsistence farming. The healthcare system in Laos is still developing, and there is a lack of basic healthcare facilities in many areas. This has resulted in a low demand for vaccines, including Other Vaccines.
Underlying macroeconomic factors: The slow growth of the Other Vaccines market in Laos can be attributed to the low demand for vaccines due to a lack of awareness and access to basic healthcare facilities. However, the government's efforts to improve the healthcare system and increase awareness about the importance of vaccines may lead to an increase in demand in the future. Additionally, the country's developing economy and heavy reliance on agriculture may limit the growth of the healthcare sector, including the Other Vaccines market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
